SummaryAI generated
Novartis announced the suspension of its clinical studies on autoimmune cell therapy due to patient deaths during the research process. The company stated that it would conduct a comprehensive review of the study’s safety and re-evaluate the subsequent trial protocols.
Related eventsRELATED EVENTS
- 2026-09-04 22:32Nvidia acquired the open-source AI platform Hugging Face for approximately $12.93 billion.
- 2026-09-08 22:17French AI company Mistral received a $3 billion Series D financing led by Samsung, with a valuation of over 21 billion euros
- 2026-09-07 18:49①MIIT: To fully build a new generation of communication network that is comprehensive and advanced in performance; ②Huawei releases the high-performance chip Kirin 9050 Pro after six years; ③Aojie Technology: Alibaba reduced its holdings in the company by 5.2831 million shares from August 17 to September 7.
Key entitiesKEY ENTITIES
Novartis
SignalsSIGNALS
Keyword heat